I’ve arrived at ESMO a little weary from the red eye to Milan from New York and looking forward to an interesting meeting.
Several blog readers have already come up to say hello so if you’re here, don’t be shy – do introduce yourselves!
The industry symposia are tomorrow (Friday) but I’m particularly looking forward to the prostate cancer session on Monday. We should get to see what the Cougar/JNJ abiraterone data looks like in taxane refractory castration resistant prostate cancer. It’s not often when we hear of 3 major improvements in overall survival in one tumour in a year, making 2010 a very interesting area for this disease with the earlier approvals of Provenge and Jevtana.
It’s going to a fun meeting. Watch this space over the weekend for highlights.